[Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
D002738:Chloroquine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D011164:Porphyrias / Q000188:drug therapy* / Q000276:immunology; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology
C023676:chloroquine diphosphate; D002738:Chloroquine
Kliniko-immunologicheskoe obosnovanie terapevticheskoĭ éffektivnosti delagila pri pozdneĭ kozhnoĭ porfirii.